{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:52:31Z","timestamp":1790423551951,"version":"4.1.0"},"reference-count":13,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Stroke"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Mechanical thrombectomy (MT), the standard of care for acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO), is generally not offered to patients with large baseline infarct (core). Recent studies demonstrated MT benefit in patients with anterior circulation stroke and large core (i.e. Alberta Stroke Program Early Computed Tomography Score, ASPECTS 3\u20135). However, its benefit in patients with the largest core (ASPECTS 0\u20132) remains unproven.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To compare the efficacy and safety of MT plus best medical treatment (BMT) and of BMT alone in patients with ASPECTS 0\u20135 (baseline computed tomography (CT) or magnetic resonance imaging (MRI)) and anterior circulation LVO within 7\u2009h of last-seen-well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Sample size estimate:<\/jats:title>\n                    <jats:p>To detect with a two-sided test at 5% significance level (80% power) a common odds ratio of 1.65 for 1-point reduction in the 90-day modified Rankin Scale (mRS) score in the MT\u2009+\u2009BMT arm versus BMT arm and to anticipate 10% of patients with missing primary endpoint, 450 patients are planned to be included by 36 centers in France, Spain, and the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and design:<\/jats:title>\n                    <jats:p>LArge Stroke Therapy Evaluation (LASTE) is an international, multicenter, Prospectively Randomized into two parallel (1:1) arms, Open-label, with Blinded Endpoint (PROBE design) trial. Eligibility criteria are diagnosis of AIS within 6.5\u2009h of last-seen-well (or negative fluid-attenuated inversion recovery (FLAIR) if unknown stroke onset time), ASPECTS 0\u20135 (ASPECTS 4\u20135 for \u2a7e80-year-old patients), and LVO in the anterior circulation (intracranial internal carotid artery (ICA) and M1 or M1\u2013M2 segment of the middle cerebral artery (MCA)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study outcomes:<\/jats:title>\n                    <jats:p>The primary endpoint is the day-90 mRS score distribution (shift analysis) with mRS categories 5 and 6 coalesced into one category. Secondary endpoints include day-180 mRS score, rates of 90-day and 180-day mRS score\u2009=\u20090\u20132 and 0\u20133, rate of decompressive craniectomy, the National Institutes of Health Stroke Scale (NIHSS) score change, revascularization and infarct volume growth at 24\u2009h, and quality of life at day 90 and 180. Safety outcomes (90-day all-cause mortality, procedural complications, symptomatic intracerebral hemorrhage, and early NIHSS score worsening) are recorded. A dynamic balanced randomization (1:1) is used to distribute eligible patients into the experimental arm and control arm, by incorporating the center and these pre-specified factors: baseline ASPECTS (0\u20133 vs 4\u20135), age (\u2a7d70 vs &gt;70\u2009years), baseline NIHSS (&lt;20 vs \u2a7e20), intravenous thrombolysis (no vs yes), admission mode (Drip-and-Ship vs Mothership), occlusion site (intracranial ICA vs MCA\u2014M1 or M1\u2013M2), intravenous fibrinolysis (no vs yes), and last-seen-well to randomization time (0\u20134.5 vs &gt;4.5\u20136.5\u2009h).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The LASTE trial will determine MT efficacy and safety in patients with ASPECTS 0\u20135 and LVO in the anterior circulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>LASTE Trial NCT03811769.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17474930231191033","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T05:07:27Z","timestamp":1689656847000},"page":"114-119","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":67,"title":["Evaluation of acute mechanical revascularization in large stroke (ASPECTS \u2a7d5) and large vessel occlusion within 7\u2009h of last-seen-well: The LASTE multicenter, randomized, clinical trial protocol"],"prefix":"10.1177","volume":"19","author":[{"given":"Vincent","family":"Costalat","sequence":"first","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Gui de Chauliac, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lapergue","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Foch, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Albucher","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Pierre-Paul Riquet, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Henon","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Salengro, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-4464","authenticated-orcid":false,"given":"Benjamin","family":"Gory","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Central, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sibon","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Pellegrin, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-9205","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Boulouis","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Bretonneau, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cognard","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Pierre-Paul Riquet, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreddine","family":"Nouri","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Salengro, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Richard","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Central, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-7753","authenticated-orcid":false,"given":"Gauthier","family":"Marnat","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Pellegrin, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Di Maria","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Foch, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Annan","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Bretonneau, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cagnazzo","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, H\u00f4pital Gui de Chauliac, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Jovin","sequence":"additional","affiliation":[{"name":"Cooper Neurological Institute, Camden, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-1039","authenticated-orcid":false,"given":"Caroline","family":"Arquizan","sequence":"additional","affiliation":[{"name":"Department of Neurology, H\u00f4pital Gui de Chauliac, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the LASTE Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"bibr1-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X"},{"key":"bibr2-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30177-6"},{"key":"bibr3-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01341-6"},{"key":"bibr4-17474930231191033","volume":"50","author":"Powers WJ","year":"2019","journal-title":"Stroke"},{"key":"bibr5-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-014568"},{"key":"bibr6-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118191"},{"key":"bibr7-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214403"},{"key":"bibr8-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213379"},{"key":"bibr9-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30242-4"},{"key":"bibr10-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-015237"},{"key":"bibr11-17474930231191033","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2021.00724"},{"key":"bibr12-17474930231191033","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010049"},{"key":"bibr13-17474930231191033","first-page":"1","volume":"45","author":"van Buuren S","year":"2011","journal-title":"J Stat Software"}],"container-title":["International Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930231191033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17474930231191033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17474930231191033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:22:11Z","timestamp":1777706531000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17474930231191033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1177\/17474930231191033"],"URL":"https:\/\/doi.org\/10.1177\/17474930231191033","relation":{},"ISSN":["1747-4930","1747-4949"],"issn-type":[{"value":"1747-4930","type":"print"},{"value":"1747-4949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}